641 related articles for article (PubMed ID: 20576697)
1. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
[TBL] [Abstract][Full Text] [Related]
3. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
4. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
5. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
[TBL] [Abstract][Full Text] [Related]
6. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.
Winter Y; Spottke AE; Stamelou M; Cabanel N; Eggert K; Höglinger GU; Sixel-Doering F; Herting B; Klockgether T; Reichmann H; Oertel WH; Dodel R
Neurodegener Dis; 2011; 8(6):438-46. PubMed ID: 21576919
[TBL] [Abstract][Full Text] [Related]
8. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
Gerstenecker A; Mast B; Duff K; Ferman TJ; Litvan I;
Arch Clin Neuropsychol; 2013 Mar; 28(2):104-13. PubMed ID: 23127882
[TBL] [Abstract][Full Text] [Related]
9. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
[TBL] [Abstract][Full Text] [Related]
10. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
[TBL] [Abstract][Full Text] [Related]
11. Social cognitive deficits and their neural correlates in progressive supranuclear palsy.
Ghosh BC; Calder AJ; Peers PV; Lawrence AD; Acosta-Cabronero J; Pereira JM; Hodges JR; Rowe JB
Brain; 2012 Jul; 135(Pt 7):2089-102. PubMed ID: 22637582
[TBL] [Abstract][Full Text] [Related]
12. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
13. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
[TBL] [Abstract][Full Text] [Related]
14. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
Miki Y; Foti SC; Asi YT; Tsushima E; Quinn N; Ling H; Holton JL
Brain; 2019 Sep; 142(9):2813-2827. PubMed ID: 31289815
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment in progressive supranuclear palsy is associated with tau burden.
Koga S; Parks A; Kasanuki K; Sanchez-Contreras M; Baker MC; Josephs KA; Ahlskog JE; Uitti RJ; Graff-Radford N; van Gerpen JA; Wszolek ZK; Rademakers R; Dickson DW
Mov Disord; 2017 Dec; 32(12):1772-1779. PubMed ID: 29082658
[TBL] [Abstract][Full Text] [Related]
16. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
[TBL] [Abstract][Full Text] [Related]
17. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
[TBL] [Abstract][Full Text] [Related]
18. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]